Prospects for exploring the molecular-genomic foundations of therapeutic hypnosis with DNA microarrays.
A new perspective on how therapeutic hypnosis and neuroscience may be integrated on the molecular-genomic level is offered as a guide for basic research and clinical applications. An update of Watson and Crick's original formulation of molecular biology is proposed to illustrate how psychosocial experiences modulate gene expression, protein synthesis, and brain plasticity during memory trace reactivation for the reorganization of neural networks that encode fear, stress, and traumatic symptoms. Examples of the scientific literature on DNA microarrays are used to explore how this new technology could integrate therapeutic hypnosis, neuroscience, and psychosocial genomics as a new foundation for mind-body medicine. Researchers and clinicians in therapeutic hypnosis need to partner with colleagues in neuroscience and molecular biology that utilize DNA microarray technology. It is recommended that hypnotic susceptibility scales of the future incorporate gene expression data to include the concept of "embodied imagination" and the "ideo-plastic faculty" on a molecular-genomic level as well as the psychological and behavioral level of ideomotor and ideosensory responses that are currently assessed.
Rossi
Ernest Lawrence
EL
Ernest@ErnestRossi.com
D001921:Brain / Q000502:physiology; D003299:Cooperative Behavior; D015870:Gene Expression / Q000502:physiology; D006801:Humans; D006990:Hypnosis / Q000379:methods*; D007092:Imagination; D019222:Mind-Body Relations, Metaphysical; D008967:Molecular Biology; D009415:Nerve Net / Q000503:physiopathology; D009473:Neuronal Plasticity / Q000235:genetics; D009488:Neurosciences; D020411:Oligonucleotide Array Sequence Analysis; D011603:Psychophysiology; D012106:Research